1

b afnj k xk ¡ / k h d-jk -ch - vLirky INDIRA GANDHI E.S.I. HOSPITAL

f>yfey] fnYyh&110 095Jhilmil, Delhi-110095.

(An ISO -9001:2008 CERTIFIED)

Tele: 011- 22151329, Fax: 011- 22167518

File No. 113/U/16/24/17/2011/Lab - Med. Dated: 26 /09 /2014

To

M/s._______________________________________________________________________________________

Subject: OPEN TENDER FOR CARRYING OUT LABORATORY (LAB.) INVESTIGATIONS UNDER TWO-BID SYSTEM

(To be returned duly completed latest by 17/10/2014 upto 1.00 PM, otherwise tender shall not be accepted.)

Sir, Medical Superintendent, I.G. ESI Hospital, Jhilmil, Delhi invites open tender forcarrying out lab investigations under two-bid system as per list of test and terms and conditions enclosed.

Tender should be submitted in sealed envelope & superscripted “Tender forcarrying out lab. investigations” in the office of Medical Superintendent, I.G. E.S.I. Hospital, Jhilmil, Delhi in the tender box placed in the chamber of Dy. Medical Superintendent latest by dated 17/10/2014 upto 1.00 p.m. In case the Tender is sent by post, it must reach in the Office of Medical Superintendent by dated 17/10/2014 up to 1.00 p.m. Proof of postage won’t be considered as a claim for timely submission of tender. The tender shall be opened on dated 17/10/2014 at 3.00 p.m. in Hospital Committee Room in presence of tenderers or their representative who wish to be present. In case 17/10/2014 is declared holiday bids will be opened on next working day at the same time and venue.

Two separate bids superscripting viz “Technical Bid” & “Financial Bid” further encased together in a sealed envelope superscribed “Tender for carrying out Lab.Investigations” be submitted and number of envelopes inserted therein should be mentioned clearly on the main envelope.

2

Tender document can also be downloaded from the website of ESIC‘www.esic.nic.in’ In case the tender form is downloaded from the website the applicant will have to deposit tender document fee of Rs.500/- (non refundable) in form of Demand Draft in favour of “ESI FUND A/C No. 1” at the time of submitting the tender.

Encl: - As above.

(Page No. 1 to 41) -Total pages Dy. Medical Superintendent(Page No. 9 to 27) -Technical Bid(Page No. 28 to 41) -Financial Bid

3

TENDER FOR PROVIDING LABORATORY INVESTIGATIONFOR IGESI HOSPITAL JHILMIL DELHI-110095

TO BE RETURNED DULY COMPLETED

Last date of submission: 17/10/2014 upto 1.00 P.M.

Venue: Chamber of Dy. Medical Superintendent, Administrative Block, IGESI Hospital, Jhilmil, Delhi

Date of opening tender: 17/10/2014 at 3.00 P.M.

Venue: Committee Room, Administrative Block, IGESI Hospital, Jhilmil, Delhi

To,

The Medical Superintendent,IG ESI Hospital,Jhilmil, Delhi-95

Subject: - Sealed quotations for providing Lab Investigations.

Sir,

In response to your advertisement in The Times of India dated / /2014 onthe subject mentioned above, I am submitting sealed quotation in two bids i.e. Technical Bid &Financial Bid for providing Lab investigation for IGESI Hospital, Jhilmil, Delhi. Earnest money ofRs. 3,00,000/- (Rupees Three Lacs only) in the form of Demand Draft No. ___________________ dated ___________ favouring “ESI Fund A/c No.1” is also enclosed.

I am also remitting the document fee of Rs.500/- (non refundable) in favour of“ESI FUND A/C No. 1” vide DD No.______________ dated_______________. (Applicable fortender document downloaded from website of ESIC)

I have carefully gone through and understood the contents of the terms andconditions of the tender and I under take to abide myself by all the terms and conditions setforth in the tender documents.

Yours faithfully,

(SIGNATURE)Name and addressContact No.Fax No.E.Mail ID/ Website address/Mobile No.

4

TERMS AND CONDITIONS

1. The contract will remain in force for a period of two years from the date ofcommencement and may be extended beyond two years on mutual acceptance, if sodesired by the Medical Superintendent.

2. Laboratory should be located in Delhi and Firm should have experience of providing full 24 hours Lab. services support to atleast 100 bedded hospital under Central Govt. /Govt. of NCT Delhi/PSUs/ESIC for minimum three years.

3. The tenderer must have necessary in house (at the quoted Lab premises) facilities formost of the tests in respect of latest technology & technical knowledge to carry out theLab investigations round the clock for which rates are being quoted. With each testit should be mentioned whether the test is conducted in house or outsourced. In case ofoutsourced investigations, the details of laboratory to which the investigation is to beoutsourced must be provided in the Technical Bid. The methodology and the timeperiod after which the report will be provided should be mentioned for each investigation.

4. A status report on the infrastructure facilities available with the tenderer in support of histechnical capability to execute the quoted Lab investigations must accompany the tenderhighlighting details of equipment, type of procedure and details of qualification &experience of manpower, whether full time or part-time, engaged for conducting the quotedinvestigations, quality control measures (including document proofs) , and automation invarious sections of laboratory. The tenderer will be liable for all types of responsibilities including medico-legal either in house or outsourced investigations

5. The tenderer should have complete functioning laboratory including a) microbiological investigations; b) molecular biology – genetics investigations (such as PCR, Karyotyping) and c) histopathological investigations. All three parts of these services should be in house.

6. The tenderer should have atleast 5 years of continuous NABL certification.

7. The tender must accompany an Earnest Money of Rs.3,00,000/- (Rs. Three Lacs only) by Bank/Demand Draft in favour of “ESI FUND A/C No.1”. Tender received without EMD/Tender cost will be rejected out rightly, which is refundable to the tenderer. No interest will be paid for such amount.

8. The successful tenderer must submit the Security Money of Rs. 6,50,000/-(Rupees Six Lacs Fifty Thousand only) in the shape of Demand Draft issued in favour of “ESI Fund Account No.1”, which will be kept in the hospital as performance security for the period ofservices awarded. No interest will be paid on such security. The said security will beforfeited in case of successful tenderer fails to provide satisfactory services/ unduedelay in providing services or leaving the contract in the middle of the contract period.

9. In case the firm to whom the contract is awarded, fails to accept the offer, the MedicalSuperintendent shall have the right to forfeit the earnest money deposited by the firm. Nocorrespondence/conference in this regard will be entertained.

10. The tenderer shall have to mention his name and address (along with the telephone, Fax,Mobile numbers) for all future communications and shall be the sole signatory of thequotation.

5

11. Tenderer must undertake at the time of applying for tender that he has perused theterms and conditions of the tender and the same are acceptable to him. Anyconditional acceptance shall make tender liable for rejection.

12. Tender is required to be submitted in two bids viz ‘Technical Bid’ and ‘FinancialBid’ separately superscribing on the envelopes as ‘Technical Bid’ and “Financial Bid’respectively. Each and every page of the quotation is to be serially numbered and dulysigned by authorized signatory/tenderer. Both the envelopes are to be put in a singleenvelope superscribing “Tender for carrying out Lab. investigations” with name of thetenderer and specifying the number of sealed envelopes enclosed/inserted.

13. (A) Technical bid:- This should include following :

(i) EMD to be furnished in accordance with serial No.7 of Terms & Conditions.(ii) Terms & Conditions duly signed by the tenderer along with seal.(iii)Technical details of the quoted tests as per following format:(Annexure I)

S.NO. Name of the test

Name & address of Laboratory, in case outsourced

Methodology/technique used

Maximum time required forsubmission of report to thehospital

NABL (Yes/ No)

(iv) In case of cultures, the tenderer should quote rates both for with antibioticsensitivity and without antibiotic sensitivity. Details of antibiotics are enclosed in Annexure– II, out of which the selection for sensitivity test is to be made by technical expert as perprescribed suitable spectrum depending upon the growth of organism.

(v) If any test not included in the Annexure-I, the tenderer should perform all such investigations by their own lab or outsourced lab (should be NABL certified Lab.).

(vi) If any test which is referred and the tenderer is unable to perform due to any reason with proper justification of unlisted/not included investigations in Annexure-I, the tenderer will be liable for all types of responsibilities including the quality of test and their reports for any medico-legal purpose and the tenderer shall be liable for any legal consequences thereof.

(vii) The award of tender shall be subject to satisfactory report of technical committee which will visit the lab for its functioning, manpower (Doctors, Technicians, Non- Technical staff), equipments, infrastructure etc.

(viii) The tenderer who has maximum number of in-house NABL tests & maximum number of in-house tests (among listed investigation in Annexure-I) will be preferred.

6

(ix) The Histopathology slides of all specimen sent will be provided by the outsourcedlab. Blocks will be provided as and when demanded without any extra amount by theoutsourced lab.

(B) Financial Bid: - It should comprise of following:-

(i) All pages of the quotation must be signed by the tenderer and the rates should be given both in figures and words.

(ii) In case of variation in rates, rates quoted in the figure will be treated as final.

(iii) The prices of the tests should be indicated in the Financial Bid against the name of each test as per format given below:- (Lists of tests as per Annexure III)

S.NO. Name of the test Rate (In figures) Rate (In words)

(iv) The Financial Bid of only those tenderers whose technical bid is fully accepted by the T.E.C., shall be opened.

14. The successful tenderer shall execute an agreement containing all the terms andconditions mentioned in the tender document on a non-judicial stamp paper of Rs.100/-(Rs. One Hundred only) and he will have to deposit security money of Rs. 6,50,000/-(Rupees Six Lacs Fifty Thousand only) in the form of Demand Draft in favour of “ESI FUND A/C No.1” payable at Delhi. No interest shall be payable on said deposit (Security money) in anycircumstances. The amount of Security Deposit shall be refunded on the expiry of thecontract on furnishing “No Dues Certificate”.

15. The rates of specific/special tests should be procedure based whether they are performed by various techniques like RIA/ELISA/PCR or any other methodology used.

16. In case the agency/firm fails to execute the job after entering into the contract orterminate the contract before completion of period of contract at their own accord, theMedical Superintendent shall have the right to forfeit the security money deposited by the firm for execution of contract for the remaining period through some other firm.

17. Bills are to preferred immediately after completion of a month in triplicate along with thethird copy of the reports of investigations. They are to be submitted to central Diary in theoffice of Medical Superintendent, IG ESI Hospital, Jhilmil, Delhi. Income Tax deduction asapplicable shall be made at source at the time of release of payment. Payment of bill will besubject to deduction of statuary liabilities, if any.

7

18. The tenderer should have 24 hours working/functioning laboratory so that the collection of samples, reporting of tests and despatching of reports of all the investigations should be done round the clock.

19. In case of inability to collect samples from the hospital as per the requirement of thehospital or not furnishing test report within stipulated time, a penalty up to Rs.500/-(Rupees Five Hundred only) per such instance may be levied on the tenderer by theMedical Superintendent and any extra cost incurred whatsoever by the ESI Corporationon analysis of samples from the open market shall be recovered from the tenderer bydeducting the same from the monthly bills.

20. In case of wrong diagnosis resulting out of incorrect reporting of samples, the legalliability arising out of it, if any, shall entirely rest with the tenderer with cost and damagesapplicable.

21. An undertaking should be enclosed with tender document that the firm is not chargingrates lower than quoted in his present quotation, from any other Institute/Hospital inDelhi.

22. In case of any dispute, the decision of the Medical Superintendent shall be final andbinding on both the parties.

23. M.S. reserves the right to reject or accept any tender without assigning any reasonthereof. M.S. also reserves the right to terminate the tender/offer after itsapproval at any time during the currency of the tender period, if the performance isfound not to be satisfactory or the tenderer fails to provide the services.

24. The terms and condition contained herein shall form part of/shall be taken as if theywere included in the contract agreement to be entered into by the firm.

25. The quotation would be valid for a period of six months.

26 The evaluation of technical bid will be based on presence of trained manpower,automation, infrastructure alongwith latest technology presence of in-house facility andmaximum time taken to provide the reports.

27. The tariff list available with the firm shall be provided by the tenderer at the time of contract, which will be valid during the contract period.

28. The rates of unlisted tests shall be applicable either as per CGHS/AIIMS rates, and if not available in CGHS/AIIMS rates, then rates shall be calculated on the rates provided by the tenderer in their tariff list after deduction of 15%.

8

29. COLLECTION OF SAMPLES

The successful tenderer shall make his own arrangement at his cost to get thesamples collected from the department of Pathology everyday under recommendedconditions specific for the samples. Routine samples drawn/obtained from OPDpatients and wards must be collected between 11:00 a.m. to 12:00 Noon everyday andin case of any emergency investigations the sample must be collected as and wheninformed telephonically round the clock . The contact number of the tenderer forthis purpose shall have to be furnished in his tender. He shall have to providecontainers for collecting all samples outsourced. The samples are to be received alongwith the requisite requisition slips in duplicate.

30. SUBMISSION OF REPORTS

Time, latest technology/methodology and accuracy in result would be the essenceof the contract/offer. The approved tenderer shall have to make necessaryarrangement at his cost to deliver the reports of investigations of samples collected dulysigned by the competent authority within the minimum possible time to the department oflab services. In emergency cases reports may also be asked/communicatedtelephonically & to be followed by delivery of written reports. The reports shall have tobe prepared in triplicate out of which two copies should be sent to the department of labservices immediately. The third copy shall be enclosed in one bunch later on along withthe bills.

31. In case of any emergency investigation, the report of the test must be available as early as possible or maximum within four hours from the time of collection of the sample, either by telephonically/e-mail/fax to the concerned person.

32. The contract can be terminated by the Medical Superintendent, I.G. ESI Hospital, Jhilmilby giving one month’s notice.

33. The Medical Superintendent reserves the right to amend or withdraw any of the termsand condition contained in the tender document.

9

TECHNICAL BID

Annexure I

LABORATORY INVESTIGATIONS FOR THE YEAR 2014-15

S.No. Name of the Test Name & address of Laboratory,

in case outsourced

Methodology/ Technique

used

Maximum time

required for

submission of

report to the

hospital

NABL (Yes/No)

1 ABO & Rh grouping (Tube Method)

2 ABO & Rh grouping (Gel Method) 3 Acetycholinesterase 4 Acid phosphatase, Serum (Total)

5 Acid phosphatase, Prostatic 6 Activated partial Thromboplastin

time 7 Adenosine Deaminase 8 Adreno corticotropic hormone

(ACTH) 9 Albert staining

10 Aldosterone serum 11 Alkaline phosphatase bone

specific 12 Alpha-1 anti trypsin quantitative 13 Alpha fetoprotein with titre 14 17,Alpha hydroxy progesterone

urine/blood 15 Ameobic serology 16 Ammonia Level blood

17 Amylase Serum/Other body fluid

18 Anaerobic culture with

sensitivity testing

10

19 Androstenedione 20 Angiotensin converting enzyme 21 Anti cardiolipin antibodies IgA/IgG/

IgM 22 Anti cardiolipin antibodies IgG 23 Anti cardiolipin antibodies IgM 24 Anti cardiolipin antibodies IgA 25 Anti DNA antibody 26 Anti double stranded DNA 27 Antibodies (ds-DNA) with titres 28 Anti histone Antibody 29 Anti Leishmania Antibody 30 Anti leprosy antibodies 31 Anti Malaral Antibodies 32 Antimitochondrial Antibody (AMA)

33 Anti Neutrophil cytoplasmic

Antibodies (ANCA) 34 Anti Neutrophil cytoplasmic

Antibodies ( c ) 35 Anti Neutrophil cytoplasmic

Antibodies (p) 36 Anti Nuclear Factor (ANF) 37 Anti Parietal Cell Antibodies IgG 38 Anti Phospholipid Antibodies 39 Anti Platelet Antibodies 40 Anti RNP SM Complex IgG 41 Anti RNP SM Complex IgM 42 Anti Smooth Muscle Antibody 43 Anti Sperm Antibodies 44 Anti SSA IgG (RO) 45 Anti SSB IgG (La) 46 Anti Thrombin-III 47 Anti Thyroid Antibodies (Anti

thyroid peroxidase antibody) 48 Anti Thyroid Antibodies

(antithyroglobulim antibody) 49 Anti Varicella Zoster IgM & IgG 50 Apolipoprotein A1 & Apolipoprotein

A2 51 ASO – Titre 52 Aspergillus antibodies IgE

11

53 Aspergillus antibodies IgG 54 B. Urea 55 Barbiturates 56 Benzodiazepines & metabolites 57 Beta 2 microglobulin 58 Beta –HCG (Serum/Urine) 59 Blood sickling (Sickling Test) 60 Blood sickling (Sickling Solubility

Test) 61 Breast Cancer Markers (ER, PR,

Her-2 Neu) 62 Breast Carcinoma Estrogen

Receptor (ER) 63 Breast Carcinoma Progesterone

Receptor (PR) 64 Breast Carcinoma: Her-2 Neu

(IHC) 65 Her- 2 Neu (Fish) 66 Brucellosis serology- Titre

(Agglutination test) 67 C-3 Levels 68 C-4 Levels 69 C-5 level 70 CA-125 (Ovarian) 71 CA-15.3 (Breast) 72 CA-19.9 (Pancreatic) 73 CA-72.4 (Gastric) 74 Calcitonin 75 Calcium total & ionized 76 Candida Albicans antibodies IgM/

IgG Serum 77 Carbamazepine level 78 Carcino Embryonic Antigen (CEA) 79 Catecholamine-Plasma 80 Cathepsin-D 81 CD-4 Cell count 82 CD-4-Percent 83 Cerruloplasmin level 84 Chromosomal Analysis

(Karyotype)

85 CK-MB

12

86 Copper serum 87 Copro Porphyrins-Serum 88 CMV avidity test, IgG 89 CMV qualitative/ quantitative

PCR 90 Cortisol,( Urine/Serum) 91 CPK 92 CRP 93 CRP (hs) 94 Cryptococcus antigen-serum 95 Cryptococcus antibodies 96 CSF Electrophoresis 97 Culture Stool with sensitivity 98 Culture Blood with sensitivity 99 Culture body fluid with

sensitivity 100 Culture sputum with sensitivity 101 Culture Urine with sensitivity 102 Culture swab with sensitivity 103 Culture pus with sensitivity 104 Culture catheter tip with

sensitivity 105 Culture AFB (Any sample) 106 Culture AFB with ABST 107 Culture CSF with sensitivity 108 Culture HVS with sensitivity 109 Culture Treachal Tip with

sensitivity 110 Culture Corneal swab with

sensitivity 111 Culture semen and other

urethral discharge with senstivity

112 Cyclosporine 113 Cysticerosis serology 114 Chikinguniya virus- IgM 115 EBV antibodies IgM, IgG 116 Cytomegalovirus (CMV) )IgG 117 Cytomegalovirus (CMV) )IgM

118 Dehydroepiandrosterone

Sulphate(D.H.E.A.)

13

119 Dengue virus IgG & IgM antibodies Qualitative

120 11 Deoxycortisol 121 Digoxin level 122 DNA ploidy and S phase

fraction 123 Drinking water microbiological

Assay as per ISI spec. 124 Epidermal growth factor

receptor 125 Epinephrine-Plasma 126 Estriol ( Total) 127 Estradiol-Serum 128 Factor IX Assay 129 Factor VIII Assay 130 Faecal Fat Estimation 131 Ferritin 132 Testosterone 133 Fetal HB (Manual Method) 134 Fibrionogen Degradation

product (FDP) Blood/ Urine 135 Fibrinogen levels 136 Flowcytometry 137 Factor- V leiden mutation 138 FIGLU (N- Formiminalglutamic

Acid) 139 Filaria Antigen 140 Flouride 141 Folate ( Serum + RBC) 142 FSH 143 Free T3 144 Free T4 145 Fungal Culture 146 KOH 147 Fungal susceptibility MIC Panel 148 Gamma Glutamyl Transferase (

GGT) 149 Gastrin

14

150 Glucose-6-Phosphate Dehydrogenase (G6-PD) Qualitative

151 Glycosylated Hb 152 Gram Stain 153 Growth Hormone 154 HER 2/ Neu 155 HLA B-27 156 HPLC – Haemoglobin 157 HBV DNA Quantitative/

Quantitative 158 HCV DNA Quantitative/

Qualitative 159 HIV DNA Quantitative/

Qualitative 160 HCV Genotyping 161 Haemoglobin estimation 162 Haemogram complete 163 Hepatitis A Virus IgM

Antibodies, IgG/ Antibodies 164 H1 N1 (Swine Flu) Qualitative PCR 165 HPV Qualitative PCR 166 Genotype PCR 167 Hepatitis A Virus total

Antibodies 168 Hepatitis B Surface Antibodies

total with titre

169 Hepatitis B Surface Antibodies IgM with titre

170 Hepatitis B surface antigen 171 Hepatitis Be virus antigen 172 Hepatitis B core antigen 173 Hepatitis B core antibody total

174 Hepatitis B core antibody IgM/

IgG

175 Hepatitis C virus antibody

15

176 Hepatitis C virus RNA quantitative/ Qualitative genotyping

177 Hepatitis C virus RNA Qualitative

178 Hepatitis E Virus IgM & IgG 179 Herpes Simplex Virus IgG

Type-I Antibodies 180 Herpes Simplex Virus IgG

Type-II Antibodies 181 Herpes Simplex Virus IgM Type

–I Antibodies 182 Herpes Simplex Virus IgM Type

–II Antibodies 183 Herpes Simplex Virus Types 1

& 2 IgM antibodies ( Combined) 184 Hepatitis B drug resistance

Genotyping 185 HIV Drug resistance genotyping 186 HIV 1 & 2 by ELISA 187 HIV- I & II rapid test 188 HIV 1 & 2 antibodies IgG CSF/

Serum/ Blood 189 HIV-1 Antigen (P24-Serum) 190 HIV-1 RNA, Qualitative 191 HIV-1 RNA, Quantitative 192 Histopathology-Small specimen

( one block) 193 Histopathology –Large

specimen (one block)

194 Histopathology-Large specimen ( Multiple block)

195 Hydatid Serology

196 Immunoglobulin Estimation IgA

Serum

197 Immunoglobulin Estimation IgD Serum

16

198 Immunoglobulin Estimation IgE Serum

199 Immunoglobulin Estimation IgG Serum

200 Immunoglobulin Estimation IgM Serum

201 Inorganic phosphorus 202 Insulin Assay 203 Inhibin A. 204 India Ink test for Cryptococcus 205 IGF1 (Insulin Like Growth

Factor- 1) 206 K-ras mutation 207 IGFBP3 (Insulin Like Growth

Factor Binding Protein 3) 208 Leishmania antibody IgG 209 LDH 210 LDH Isoenzymes H1 to H5 211 Lead levels 212 Lepra Bacilli Staining 213 Leukocyte Alikaline Phophatase 214 Leptospirosis-IgG antibodies 215 Leptospirosis-IgM antibodies 216 Lithium 217 Lupus anti coagulant 218 LH-Serum 219 Latex Agglutination test for

Cryptococcus 220 Latex Agglutination test for 221 Streptococcus 222 Latex Agglutination test for

Pneumococcus

223 Microalbuminuria (MAU)

224 Mycobacterium Tuberculosis PCR from body fluid

225 MCV

226 MCH

227 MCHC

17

228 Methotrexate 229 Lipid profile 230 Mumps virus antibody IgG/ IgM

231 Measles virus antibody IgG 232 Measles virus antibody IgM 233 Modified Z. N. Staining 234 Norepinephrine-Plasma 235 Operation theatre/

Nursery/Ward/I.C.U. microbiological surveillance Swab/ Plate

236 Osmolarty, Blood/ Urine 237 Osmotic fragility test 238 Parathormone 239 Paul Bunnel Test 240 PCR for HIV 241 PCR Hepatitis B Viral DNA 242 PCR Hepatitis C Viral RNA 243 PCR for Cryptococcus 244 PCR for Pneumococcus 245 PCR for Gonococcus 246 Phenobarbitone 247 Phenytoin (Dilantin) 248 Plasma Renin activity 249 Pheumocystic Carinil detection 250 PNH Confirmatory test (HAM

Test) by Manual Test 251 PNH Confirmatory test (HAM

Test) - PCR by CD50, CD59 252 Potassium 253 Progesterone 254 Prolactin 255 Prostate specific antigen free 256 Prothombin time 257 APTT

258 T Thrombin Time

259 D- dimer

260 Protein C

18

261 Protein S 262 PAPP-A 263 Prostate specific antigen PSA

Total 264 Rubella Avidity IgG 265 Rheumatoid factor 266 Rubella Antibodies IgG 267 Rubella Antibodies IgM 268 Semen Fructose 269 S. Alkaline Phasphatase 270 S. Bilirubin T/D/I 271 S. Creatinine 272 SGOT 273 SGPT 274 S. Electrophoresis 275 S. Magnesium 276 S. Lipid Profile 277 Serodiagnosis for Leprosy 278 Serum Lipase 279 Sodium 280 Stone Analysis 281 Testosterone 282 Theophylline 283 Thrombin Time 284 Thyroglobulin antibody 285 Thyroid Peroxide ab. 286 Toxoplama avidity IgG 287 Toxoplasma antibody IgM, IgG 288 Typhidot 289 Thyroxine Binding Globulin 290 Tissue Transglutaminase

antibody IgA 291 TORCH IgG 292 TORCH IgM 293 Treponema pallidum TPHA

Test

294 Thyrotropin Releasing Hormones

295 Troponin-T

19

296 TSH 297 Urinary Catecholamines 298 Urine 17 Alpa Hydroxy 299 progesterone 300 Urine 17 hydroxy

corticosteroids 301 Urine Copper 302 Urine Coproporphyrin 303 Urine VMA 304 Urine Sodium Pottasium 305 Urine Calcium 306 Valproic Acid 307 Valproate 308 Vit. B-12 309 Vit. B-6 310 Vit. D3 311 Western Blot HIV 312 Growth Hormone Releasing

Hormone 313 Growth Hormone

Stimulation/Suppression Test 314 VARICELLA Zostor antibody

IgM/ IgG 315 Widal Slide Agglutination test 316 Triple Marker test (AFP, B-HCG,

E-3) 317 Electrolytes, Na,K 318 Electrolytes Chlorides 319 Electrolytes Bicarbonate 320 Anti LKM Antibody 321 Serum Vit. D level 322 S. Lead level 323 Chlamydial IgG 324 Chlamydial IgM 325 Creatnine Clearance Test 326 Immunocytochemistry for

Tumer 327 Immunocytochemistry 328 Anti CCP for R.A.

329 Ser. Homocystein level

20

330 Lipo protien ( a ) 331 Bac tach for T.B.(Rapid method

for T.B. culture/sensitivity 332 Factor VII 333 BNP level 334 Parathyroid Profile 335 Inhibin B maternal screen 336 ACL 337 LAC 338 Marker for soft tissue tumer 339 Ser. Mg. 340 HPV Serology 341 Anti endomysial antibody 342 Anti HBe Ag Antibody 343 Infectious mononucleosis

Serology 344 Cryo globulin 345 Anti Mullarian Harmone 346 PCR for CMV/BK virus 347 CD 8 count 348 CD 4 count 349 Dengue NS 1 test 350 Ser. Tacrolimus level 351 Haemophilus Influenza From

CSF 352 Bone Marrow 353 Chikungunya IgM (Rapid

immunochromatography) 354 Chyle Test urine 355 GFR 356 Immunohistochemistry-Round

cell Tumor 357 RBC Folate

358 Skin or Nasal Scraping for

Leprosy

359 Anti Amoebic Antibodies (Elisa)

360 Anti Helicobacter Pylori (IgA)

361 Anti Helicobacter Pylori (IgG)

21

362 Measles Virus (IgG) 363 Measles Virus (IgM) 364 Measles Virus (IgM), CSF 365 Mumps (IgG) 366 Mumps (IgM) 367 Transferrin 368 Transferrin Saturation 369 TSH Ultrasensitive 370 Alpha-Hydroxy Progesterone 371 Anti Aspergillosis IgG 372 Anti Gliadin Antibody IgA 373 Anti Gliadin Antibody IgG 374 Anti Varicella Zoster (IgM) 375 Anti HBc Antibody (Total) 376 Aspergillus Antibody 377 Aspergillus IgE 378 Catecholamine 24 hours Urine 379 Culture Bacec 380 Culture Semen 381 Cytology Malignant Cells 382 Folic Acid 383 Hepatitis Delta Antibody HDV

Antibody 384 IGF BP-3 (IGF Binding Protien

3) 385 IGF – 1 (Somatostatin C) 386 Leishmania (Kala Azar Ab) Anti

Leishmania (IgG) 387 Monospot Test for EB Virus 388 Parietal Cell Antibody Serum

(1:20) by IF 389 Porphyrin 24 hours urine 390 Porphyrin Random Urine 391 Protien C Functional 392 Protien S Functional 393 Tegretol Serum 394 TPHA 395 TPHA, CSF

396 BCR ABL test by Fish

22

397 BCR ABL PCR Qualitative/ Quantitative

398 BCR ABL- I & BCR ABL- II Mutation

399 Beta-2 Microglobulin 400 IHC- KRAS 401 IHC P53 402 IHC CD1 403 IHC Panel for benign spindle

cell soft tissue tumour 404 IHC Panel for malignant spindle

cell soft tissue tumour 405 JAK-2 mutation 406 T.B Quantiferon Gold 407 T.B. PCR

This document (list from serial number 1 to 407) is the part of Technical Bid

23

TECHNICAL BIDANNEXURE-II

LIST OF ANITBIOTICS

S.No. NAME OF ANTIBIOTIC TECHNIC USED

1 AMIKACIN

2 AMOX/CLAV

3 AMOXYCILLIN

4 AMPICILLIN

5 AMPICILLIN/SAL-BACTUM

6 AMPHOTERECIN B

7 AZITHROMYCIN

8 AZTREONAM

9 BACITRACIN

10 CARBENECILLIN

11 CEFATOXIME

12 CEFAZOLINE

13 CEFEPINE

14 CEFIXIME

15 CEFOXITIN

16 CEFPERAZONE

17 CEFPIROME

18 CEFTAZIDIME

19 CEFTAZIDIMINE CLAVULANIC ACID

20 CEFTIZOXINE

21 CECTRIAZXONE

22 CECTRIZXONE

23 CEFUROXIME

24 CEPHEDROXIL

25 CEPHODOXIME

26 CHLOROMYCETIN

27 CIPROFLOXACIN

28 CLARITHROMYCIN

29 CLINDAMYCIN

30 CO-TRIMOXAZOLE

31 COLISTIN

32 CEPHALORIDINE

33 CEFACTORCG

34 CEFDINIR

35 CEFPODOXIME

36 CEFPROZIL

24

37 CLOTIRIMAZOLE

38 CEPHALEXINE

39 CLOXACILLIN

40 CEPPHALOMIN

41 CEFTIBUTEN

42 CEFINASE WITH NITROCEFIAN

43 DOXYCYCLINE

44 DEMECLOCYCLINE

45 ETHAMBUTOL

46 ETHIONAMIDE

47 ERYTHROMYCIN

48 FURAZOCIDINE

49 FLUCONAZOLE

50 FUROXONE

51 FUSIDIC ACID

52 GRIESOFULVIN

53 GATIFLOXACIN

54 GENTAMYCIN

55 IMIPENEM

56 ITRACONAZOLE

57 KANAMYCIN

58 KETOCONAZOLE

59 LEVOFLOXACIN

60 LINCOMYCIN

61 LINEZOLID

62 LOMIFLOXACIN

63 METRONIDAZOLE

64 MOXIFLOXACIN

65 MEROPENEM

66 MICONAZOLE

67 MINOCYCLINE

68 MUPIROCIN

69 NALIDIXIC ACID

70 NEOMYCIN

71 NETILMICIN

72 NITROFLURATION

73 NORFLOXACIN

74 NOVOBIOCIN

75 NYSTAIN

76 OFLOAXCIN

77 OXACILLIN

78 OPTOCHIN

79 PEFLOXACIN

80 PENCILLIN

81 PIPER/TAZO

25

82 PIPERACILLIN

83 POLYMIXIN B

84 PRISTINOMYCIN

85 PYRAZINAMIDE

86 RIFAMPICIN

87 ROXYTHROMYCIN

88 SPARFLOXACIN

89 SPECTINOMYCIN

90 STREPTOMYCIN

91 TEICOPLANIN

92 TETRACYCLINE

93 TICRCILLIN+CLAV

94 VANCOMYCIN

This document (serial number 1 to 94) is the part of Technical Bid

26

UNDERTAKING

1. I/We__________________________________________________________S/o/D/oSh____________________________________________________Prop./Direct or/Authorized signatory is competent to sign. this declaration and executing this tender document.

2. I/we have carefully gone through the contents of the tender document and I/we undertake to abide myself/ourselves by all the terms and conditions set forth.

3. That the rates quoted are not higher than those charged from any other Institution/Hospital in Delhi.

(Signature of the Tenderer with seal)

Date:

*This Undertaking is a part of “Technical Bid”

List of documents to be enclosed with the tender document. (Technical Bid)

1. Copy of certificate of NABL accredited issued with appropriate authority.2. Undertaking3. Demand Draft for Rs.3,00,000/- (Rupees Three Lacs only) as EMD.4. Demand Draft for Rs. 500/- (Rupees Five Hundred only) as Tender Fee (in case

tender document downloaded from the website)5. List of Institutes/Hospitals to whom the similar services are being provided.6. Terms & Conditions (every page) duly signed by tenderer along with stamp/seal.7. Annexure I & Annexure II8. Status report as the infrastructure facilities available (with highlighting details of

equipment).9. Qualification & experience of man power with documentary proof (whether full time

or part time.

27

CHECK LIST FOR TECHNICAL BID

1. Tenderer should complete and submit along with tender duly filled Annexure I & II.2. NABL accreditation certificate for different branches is required.3. MOU with the outsourced Lab from where the Tenderer has contract for conducting

investigations for which in-house facility is not available.4. Undertaking regarding that the firm is not charging lower than the quoted in present

quotation from any Institution/ Hospital in Delhi.5. List of manpower with educational Qualification & experience along with List of

equipments in Lab.

(Signature of the Tenderer with seal)

28

FINANCIAL BID

Annexure III

LABORATORY INVESTIGATIONS FOR THE YEAR 2014-15

S.No.

Name of the Test Rate(in Figures)

Rate(in words)

1 ABO & Rh grouping (Tube Method)

2 ABO & Rh grouping (Gel Method)

3 Acetycholinesterase 4 Acid phosphatase, Serum

(Total) 5 Acid phosphatase, Prostatic 6 Activated partial

Thromboplastin time 7 Adenosine Deaminase 8 Adreno corticotropic hormone

(ACTH) 9 Albert staining

10 Aldosterone serum 11 Alkaline phosphatase bone

specific 12 Alpha-1 anti trypsin quantitative 13 Alpha fetoprotein with titre 14 17,Alpha hydroxy progesterone

urine/blood 15 Ameobic serology 16 Ammonia Level blood 17 Amylase Serum/Other body

fluid 18 Anaerobic culture with

sensitivity testing 19 Androstenedione 20 Angiotensin converting enzyme

21 Anti cardiolipin antibodies

IgA/IgG/ IgM

22 Anti cardiolipin antibodies IgG

29

23 Anti cardiolipin antibodies IgM 24 Anti cardiolipin antibodies IgA 25 Anti DNA antibody 26 Anti double stranded DNA 27 Antibodies (ds-DNA) with titres 28 Anti histone Antibody 29 Anti Leishmania Antibody 30 Anti leprosy antibodies 31 Anti Malaral Antibodies 32 Antimitochondrial Antibody

(AMA) 33 Anti Neutrophil cytoplasmic

Antibodies (ANCA) 34 Anti Neutrophil cytoplasmic

Antibodies ( c ) 35 Anti Neutrophil cytoplasmic

Antibodies (p) 36 Anti Nuclear Factor (ANF) 37 Anti Parietal Cell Antibodies

IgG 38 Anti Phospholipid Antibodies 39 Anti Platelet Antibodies 40 Anti RNP SM Complex IgG 41 Anti RNP SM Complex IgM 42 Anti Smooth Muscle Antibody 43 Anti Sperm Antibodies 44 Anti SSA IgG (RO) 45 Anti SSB IgG (La) 46 Anti Thrombin-III 47 Anti Thyroid Antibodies (Anti

thyroid peroxidase antibody) 48 Anti Thyroid Antibodies

(antithyroglobulim antibody) 49 Anti Varicella Zoster IgM & IgG 50 Apolipoprotein A1 &

Apolipoprotein A2 51 ASO – Titre 52 Aspergillus antibodies IgE 53 Aspergillus antibodies IgG 54 B. Urea 55 Barbiturates 56 Benzodiazepines & metabolites 57 Beta 2 microglobulin

30

58 Beta –HCG (Serum/Urine) 59 Blood sickling (Sickling Test) 60 Blood sickling (Sickling

Solubility Test) 61 Breast Cancer Markers (ER,

PR, Her-2 Neu) 62 Breast Carcinoma Estrogen

Receptor (ER) 63 Breast Carcinoma

Progesterone Receptor (PR) 64 Breast Carcinoma: Her-2 Neu

(IHC) 65 Her- 2 Neu (Fish) 66 Brucellosis serology- Titre

(Agglutination test) 67 C-3 Levels 68 C-4 Levels 69 C-5 level 70 CA-125 (Ovarian) 71 CA-15.3 (Breast) 72 CA-19.9 (Pancreatic) 73 CA-72.4 (Gastric) 74 Calcitonin 75 Calcium total & ionized 76 Candida Albicans antibodies

IgM/ IgG Serum 77 Carbamazepine level 78 Carcino Embryonic Antigen

(CEA) 79 Catecholamine-Plasma 80 Cathepsin-D 81 CD-4 Cell count 82 CD-4-Percent 83 Cerruloplasmin level 84 Chromosomal Analysis

(Karyotype) 85 CK-MB 86 Copper serum 87 Copro Porphyrins-Serum

88 CMV avidity test, IgG

89 CMV qualitative/ quantitative

PCR

31

90 Cortisol,( Urine/Serum) 91 CPK 92 CRP 93 CRP (hs) 94 Cryptococcus antigen-serum 95 Cryptococcus antibodies 96 CSF Electrophoresis 97 Culture Stool with sensitivity 98 Culture Blood with sensitivity 99 Culture body fluid with

sensitivity 100 Culture sputum with sensitivity 101 Culture Urine with sensitivity 102 Culture swab with sensitivity 103 Culture pus with sensitivity 104 Culture catheter tip with

sensitivity 105 Culture AFB (Any sample) 106 Culture AFB with ABST 107 Culture CSF with sensitivity 108 Culture HVS with sensitivity 109 Culture Treachal Tip with

sensitivity 110 Culture Corneal swab with

sensitivity 111 Culture semen and other

urethral discharge with senstivity

112 Cyclosporine 113 Cysticerosis serology 114 Chikinguniya virus- IgM 115 EBV antibodies IgM, IgG 116 Cytomegalovirus (CMV) )IgG 117 Cytomegalovirus (CMV) )IgM 118 Dehydroepiandrosterone

Sulphate(D.H.E.A.) 119 Dengue virus IgG & IgM

antibodies Qualitative 120 11 Deoxycortisol 121 Digoxin level 122 DNA ploidy and S phase

fraction

32

123 Drinking water microbiological Assay as per ISI spec.

124 Epidermal growth factor receptor

125 Epinephrine-Plasma 126 Estriol ( Total) 127 Estradiol-Serum 128 Factor IX Assay 129 Factor VIII Assay 130 Faecal Fat Estimation 131 Ferritin 132 Testosterone 133 Fetal HB (Manual Method) 134 Fibrionogen Degradation

product (FDP) Blood/ Urine 135 Fibrinogen levels 136 Flowcytometry 137 Factor- V leiden mutation 138 FIGLU (N- Formiminalglutamic

Acid) 139 Filaria Antigen 140 Flouride 141 Folate ( Serum + RBC) 142 FSH 143 Free T3 144 Free T4 145 Fungal Culture 146 KOH 147 Fungal susceptibility MIC Panel 148 Gamma Glutamyl Transferase (

GGT) 149 Gastrin 150 Glucose-6-Phosphate

Dehydrogenase (G6-PD) Qualitative

151 Glycosylated Hb

152 Gram Stain

153 Growth Hormone

33

154 HER 2/ Neu 155 HLA B-27 156 HPLC – Haemoglobin 157 HBV DNA Quantitative/

Quantitative 158 HCV DNA Quantitative/

Qualitative 159 HIV DNA Quantitative/

Qualitative 160 HCV Genotyping 161 Haemoglobin estimation 162 Haemogram complete 163 Hepatitis A Virus IgM

Antibodies, IgG/ Antibodies 164 H1 N1 (Swine Flu) Qualitative

PCR 165 HPV Qualitative PCR 166 Genotype PCR 167 Hepatitis A Virus total

Antibodies 168 Hepatitis B Surface Antibodies

total with titre

169 Hepatitis B Surface Antibodies IgM with titre

170 Hepatitis B surface antigen 171 Hepatitis Be virus antigen 172 Hepatitis B core antigen 173 Hepatitis B core antibody total 174 Hepatitis B core antibody IgM/

IgG 175 Hepatitis C virus antibody 176 Hepatitis C virus RNA

quantitative/ Qualitative genotyping

177 Hepatitis C virus RNA

Qualitative 178 Hepatitis E Virus IgM & IgG 179 Herpes Simplex Virus IgG

Type-I Antibodies

34

180 Herpes Simplex Virus IgG Type-II Antibodies

181 Herpes Simplex Virus IgM Type –I Antibodies

182 Herpes Simplex Virus IgM Type –II Antibodies

183 Herpes Simplex Virus Types 1 & 2 IgM antibodies ( Combined)

184 Hepatitis B drug resistance Genotyping

185 HIV Drug resistance genotyping 186 HIV 1 & 2 by ELISA 187 HIV- I & II rapid test 188 HIV 1 & 2 antibodies IgG CSF/

Serum/ Blood 189 HIV-1 Antigen (P24-Serum) 190 HIV-1 RNA, Qualitative 191 HIV-1 RNA, Quantitative 192 Histopathology-Small specimen

( one block) 193 Histopathology –Large

specimen (one block) 194 Histopathology-Large specimen

( Multiple block) 195 Hydatid Serology 196 Immunoglobulin Estimation IgA

Serum 197 Immunoglobulin Estimation IgD

Serum 198 Immunoglobulin Estimation IgE

Serum 199 Immunoglobulin Estimation IgG

Serum 200 Immunoglobulin Estimation IgM

Serum 201 Inorganic phosphorus 202 Insulin Assay

203 Inhibin A.

35

204 India Ink test for Cryptococcus 205 IGF1 (Insulin Like Growth

Factor- 1) 206 K-ras mutation 207 IGFBP3 (Insulin Like Growth

Factor Binding Protein 3) 208 Leishmania antibody IgG 209 LDH 210 LDH Isoenzymes H1 to H5 211 Lead levels 212 Lepra Bacilli Staining 213 Leukocyte Alikaline Phophatase 214 Leptospirosis-IgG antibodies 215 Leptospirosis-IgM antibodies 216 Lithium 217 Lupus anti coagulant 218 LH-Serum 219 Latex Agglutination test for

Cryptococcus 220 Latex Agglutination test for 221 Streptococcus 222 Latex Agglutination test for

Pneumococcus 223 Microalbuminuria (MAU) 224 Mycobacterium Tuberculosis

PCR from body fluid 225 MCV 226 MCH 227 MCHC 228 Methotrexate 229 Lipid profile 230 Mumps virus antibody IgG/ IgM

231 Measles virus antibody IgG 232 Measles virus antibody IgM 233 Modified Z. N. Staining 234 Norepinephrine-Plasma

36

235 Operation theatre/ Nursery/Ward/I.C.U. microbiological surveillance Swab/ Plate

236 Osmolarty, Blood/ Urine 237 Osmotic fragility test 238 Parathormone 239 Paul Bunnel Test 240 PCR for HIV 241 PCR Hepatitis B Viral DNA 242 PCR Hepatitis C Viral RNA 243 PCR for Cryptococcus 244 PCR for Pneumococcus 245 PCR for Gonococcus 246 Phenobarbitone 247 Phenytoin (Dilantin) 248 Plasma Renin activity 249 Pheumocystic Carinil detection 250 PNH Confirmatory test (HAM

Test) by Manual Test 251 PNH Confirmatory test (HAM

Test) - PCR by CD50, CD59 252 Potassium 253 Progesterone 254 Prolactin 255 Prostate specific antigen free 256 Prothombin time 257 APTT 258 T Thrombin Time 259 D- dimer 260 Protein C 261 Protein S 262 PAPP-A 263 Prostate specific antigen PSA

Total 264 Rubella Avidity IgG 265 Rheumatoid factor 266 Rubella Antibodies IgG

267 Rubella Antibodies IgM

37

268 Semen Fructose 269 S. Alkaline Phasphatase 270 S. Bilirubin T/D/I 271 S. Creatinine 272 SGOT 273 SGPT 274 S. Electrophoresis 275 S. Magnesium 276 S. Lipid Profile 277 Serodiagnosis for Leprosy 278 Serum Lipase 279 Sodium 280 Stone Analysis 281 Testosterone 282 Theophylline 283 Thrombin Time 284 Thyroglobulin antibody 285 Thyroid Peroxide ab. 286 Toxoplama avidity IgG 287 Toxoplasma antibody IgM, IgG 288 Typhidot 289 Thyroxine Binding Globulin 290 Tissue Transglutaminase

antibody IgA 291 TORCH IgG 292 TORCH IgM 293 Treponema pallidum TPHA

Test 294 Thyrotropin Releasing

Hormones 295 Troponin-T 296 TSH 297 Urinary Catecholamines 298 Urine 17 Alpa Hydroxy 299 progesterone 300 Urine 17 hydroxy

corticosteroids 301 Urine Copper

302 Urine Coproporphyrin

38

303 Urine VMA 304 Urine Sodium Pottasium 305 Urine Calcium 306 Valproic Acid 307 Valproate 308 Vit. B-12 309 Vit. B-6 310 Vit. D3 311 Western Blot HIV 312 Growth Hormone Releasing

Hormone 313 Growth Hormone

Stimulation/Suppression Test 314 VARICELLA Zostor antibody

IgM/ IgG 315 Widal Slide Agglutination test 316 Triple Marker test (AFP, B-

HCG, E-3) 317 Electrolytes, Na,K 318 Electrolytes Chlorides 319 Electrolytes Bicarbonate 320 Anti LKM Antibody 321 Serum Vit. D level 322 S. Lead level 323 Chlamydial IgG 324 Chlamydial IgM 325 Creatnine Clearance Test 326 Immunocytochemistry for

Tumer 327 Immunocytochemistry 328 Anti CCP for R.A. 329 Ser. Homocystein level 330 Lipo protien ( a ) 331

Bac tach for T.B.(Rapid method for T.B. culture/sensitivity

332 Factor VII

333 BNP level 334 Parathyroid Profile

335 Inhibin B maternal screen

39

336 ACL 337 LAC 338 Marker for soft tissue tumer 339 Ser. Mg. 340 HPV Serology 341 Anti endomysial antibody 342 Anti HBe Ag Antibody 343 Infectious mononucleosis

Serology 344 Cryo globulin 345 Anti Mullarian Harmone 346 PCR for CMV/BK virus 347 CD 8 count 348 CD 4 count 349 Dengue NS 1 test 350 Ser. Tacrolimus level 351 Haemophilus Influenza From

CSF 352 Bone Marrow 353 Chikungunya IgM (Rapid

immunochromatography) 354 Chyle Test urine 355 GFR 356 Immunohistochemistry-Round

cell Tumor 357 RBC Folate 358 Skin or Nasal Scraping for

Leprosy 359 Anti Amoebic Antibodies (Elisa) 360 Anti Helicobacter Pylori (IgA) 361 Anti Helicobacter Pylori (IgG) 362 Measles Virus (IgG) 363 Measles Virus (IgM) 364 Measles Virus (IgM), CSF 365 Mumps (IgG) 366 Mumps (IgM) 367 Transferrin

368 Transferrin Saturation

369 TSH Ultrasensitive

40

370 Alpha-Hydroxy Progesterone 371 Anti Aspergillosis IgG 372 Anti Gliadin Antibody IgA 373 Anti Gliadin Antibody IgG 374 Anti Varicella Zoster (IgM) 375 Anti HBc Antibody (Total) 376 Aspergillus Antibody 377 Aspergillus IgE 378 Catecholamine 24 hours Urine 379 Culture Bacec 380 Culture Semen 381 Cytology Malignant Cells 382 Folic Acid 383 Hepatitis Delta Antibody HDV

Antibody 384 IGF BP-3 (IGF Binding Protien

3) 385 IGF – 1 (Somatostatin C) 386 Leishmania (Kala Azar Ab) Anti

Leishmania (IgG) 387 Monospot Test for EB Virus 388 Parietal Cell Antibody Serum

(1:20) by IF 389 Porphyrin 24 hours urine 390 Porphyrin Random Urine 391 Protien C Functional 392 Protien S Functional 393 Tegretol Serum 394 TPHA 395 TPHA, CSF 396 BCR ABL test by Fish 397 BCR ABL PCR Qualitative/

Quantitative 398 BCR ABL- I & BCR ABL- II

Mutation 399 Beta-2 Microglobulin 400 IHC- KRAS 401

IHC P53 402 IHC CD1

41

403 IHC Panel for benign spindle cell soft tissue tumour

404 IHC Panel for malignant spindle cell soft tissue tumour

405 JAK-2 mutation 406 T.B Quantiferon Gold 407 T.B. PCR

This document (serial number 1 to 407) is the part of Financial Bid